SUPPRESSION OF BETA-LACTAM ANTIBIOTIC-RESISTANCE IN A METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS THROUGH SYNERGIC ACTION OF EARLY CELL-WALL INHIBITORS AND SOME OTHER ANTIBIOTICS
K. Sieradzki et A. Tomasz, SUPPRESSION OF BETA-LACTAM ANTIBIOTIC-RESISTANCE IN A METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS THROUGH SYNERGIC ACTION OF EARLY CELL-WALL INHIBITORS AND SOME OTHER ANTIBIOTICS, Journal of antimicrobial chemotherapy, 39, 1997, pp. 47-51
We tested the effect of a number of mechanistically distinct antibacte
rial agents on the expression of methicillin resistance in a highly an
d homogeneously resistant strain of methicillin-resistant Staphylococc
us aureus. The antibiotics, used at 0.25 x MIG, included inhibitors of
early steps in peptidoglycan synthesis (fosfomycin, beta-chloro-D-ala
nine, D-cycloserine); bacitracin; teicoplanin and vancomycin; beta-lac
tam inhibitors chosen on the basis of their relatively selective affin
ities for penicillin-binding proteins 1, 2, 3 and 4 of S. aureus (imip
enem, cefotaxime, cephradine and cefoxitin); compounds that inhibit va
rious steps in protein synthesis (tetracycline, chloramphenicol, genta
micin, erythromycin and quinupristin/dalfopristin) and an inhibitor of
DNA gyrase (temafloxacin). All inhibitors of early cell wall synthesi
s caused reduction of methicillin resistance and change from the homog
eneous to the heterogeneous methicillin-resistant phenotype. Similar e
ffects were obtained with only cephradine out of the four beta-lactams
tested, and with erythromycin and quinupristin/dalfopristin as well.
The other inhibitors of protein synthesis and DNA gyrase had no effect
.